A single unified model for fitting simple to complex receptor response data

被引:20
作者
Buchwald, Peter [1 ,2 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA
基金
美国国家卫生研究院;
关键词
MUSCARINIC ACETYLCHOLINE-RECEPTORS; PROTEIN-COUPLED RECEPTORS; BIASED AGONISM; OPERATIONAL MODELS; LINEAR-REGRESSION; HILL EQUATION; LIGAND BIAS; EFFICACY; AFFINITY; SITE;
D O I
10.1038/s41598-020-70220-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The fitting of complex receptor-response data where fractional response and occupancy do not match is challenging. They encompass important cases including (a) the presence of "receptor reserve" and/or partial agonism, (b) multiple responses assessed at different vantage points along a pathway, (c) responses that are different along diverging downstream pathways (biased agonism), and (d) constitutive activity. For these, simple models such as the well-known Clark or Hill equations cannot be used. Those that can, such as the operational (Black&Leff) model, do not provide a unified approach, have multiple nonintuitive parameters that are challenging to fit in well-defined manner, have difficulties incorporating binding data, and cannot be reduced or connected to simpler forms. We have recently introduced a quantitative receptor model (SABRE) that includes parameters for Signal Amplification (gamma), Binding affinity (K-d), Receptor activation Efficacy (epsilon), and constitutive activity (epsilon (R0)). It provides a single equation to fit complex cases within a full two-state framework with the possibility of incorporating receptor occupancy data (i.e., experimental K(d)s). Simpler cases can be fit by using consecutively reduced forms obtained by constraining parameters to specific values, e.g., epsilon (R0)=0: no constitutive activity, gamma =1: no amplification (E-max-type fitting), and epsilon =1: no partial agonism (Clark equation). Here, a Hill-type extension is introduced (n not equal 1), and simulated and experimental receptor-response data from simple to increasingly complex cases are fitted within the unified framework of SABRE with differently constrained parameters.
引用
收藏
页数:17
相关论文
共 58 条
[1]  
ARIENS EJ, 1954, ARCH INT PHARMACOD T, V99, P32
[2]   The number of subjects per variable required in linear regression analyses [J].
Austin, Peter C. ;
Steyerberg, Ewout W. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (06) :627-636
[3]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[4]   General linearized biexponential model for QSAR data showing bilinear-type distribution [J].
Buchwald, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (11) :2355-2379
[5]   A general bilinear model to describe growth or decline time profiles [J].
Buchwald, Peter .
MATHEMATICAL BIOSCIENCES, 2007, 205 (01) :108-136
[6]   A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data [J].
Buchwald, Peter .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[7]   A three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplification [J].
Buchwald, Peter .
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2017, 5 (03)
[8]   A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets [J].
Buchwald, Peter .
THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2011, 8
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   The elusive nature of intrinsic efficacy [J].
Clarke, WP ;
Bond, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (07) :270-276